Paul B. Manning - 31 Oct 2022 Form 4 Insider Report for Taysha Gene Therapies, Inc. (TSHA)

Role
Director, 10%+ Owner
Signature
/s/ Kamran Alam, Attorney-in-Fact
Issuer symbol
TSHA
Transactions as of
31 Oct 2022
Net transactions value
+$3,000,000
Form type
4
Filing time
02 Nov 2022, 16:09:10 UTC
Previous filing
17 Oct 2022
Next filing
21 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSHA Common Stock Purchase $3,000,000 +1,500,000 +1055% $2.00 1,642,202 31 Oct 2022 Direct F1
holding TSHA Common Stock 22,000 31 Oct 2022 See footnote F2
holding TSHA Common Stock 2,091,704 31 Oct 2022 See footnote F3
holding TSHA Common Stock 3,195,205 31 Oct 2022 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 1,500,000 shares of common stock held by Mr. Manning and 142,202 shares of common stock held by Mr. Manning jointly with his spouse.
F2 The shares are held directly by BKB G2 Investments, LLC ("BKB G2"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB G2, and has shared voting and investment power with respect to the shares held by BKB G2.
F3 The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB.
F4 The shares are held directly by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust.